Bender H - Search Results

1

FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.

Palmedo H, Urbach H, Bender H, Schlegel U, Schmidt-Wolf IG, Matthies A, Linnebank M, Joe A, Bucerius J, Biersack HJ, Pels H. Palmedo H, et al. Among authors: bender h. Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):164-8. doi: 10.1007/s00259-005-1917-6. Epub 2005 Oct 12. Eur J Nucl Med Mol Imaging. 2006. PMID: 16220304

2

Imaging of prostate cancer metastases with 18F-fluoroacetate using PET/CT.

Matthies A, Ezziddin S, Ulrich EM, Palmedo H, Biersack HJ, Bender H, Guhlke S. Matthies A, et al. Among authors: bender h. Eur J Nucl Med Mol Imaging. 2004 May;31(5):797. doi: 10.1007/s00259-003-1437-1. Epub 2004 Feb 20. Eur J Nucl Med Mol Imaging. 2004. PMID: 14985862 No abstract available.

3

Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer.

Grünwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, Palmedo H, Ruhlmann J, Kozak B, Biersack HJ. Grünwald F, et al. Among authors: bender h. Eur J Nucl Med. 1996 Mar;23(3):312-9. doi: 10.1007/BF00837630. Eur J Nucl Med. 1996. PMID: 8599963

4

Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.

Palmedo H, Grünwald F, Bender H, Schomburg A, Mallmann P, Krebs D, Biersack HJ. Palmedo H, et al. Among authors: bender h. Eur J Nucl Med. 1996 Aug;23(8):940-6. doi: 10.1007/BF01084368. Eur J Nucl Med. 1996. PMID: 8753683

5

Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.

Palmedo H, Bender H, Grünwald F, Mallmann P, Zamora P, Krebs D, Biersack HJ. Palmedo H, et al. Among authors: bender h. Eur J Nucl Med. 1997 Sep;24(9):1138-45. doi: 10.1007/BF01254246. Eur J Nucl Med. 1997. PMID: 9283107

6

FDG-PET in monitoring therapy of breast cancer.

Biersack HJ, Bender H, Palmedo H. Biersack HJ, et al. Among authors: bender h. Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S112-7. doi: 10.1007/s00259-004-1533-x. Epub 2004 Apr 27. Eur J Nucl Med Mol Imaging. 2004. PMID: 15112111 Review.

7

Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures.

Schomburg A, Bender H, Reichel C, Sommer T, Ruhlmann J, Kozak B, Biersack HJ. Schomburg A, et al. Among authors: bender h. Eur J Nucl Med. 1996 May;23(5):571-4. doi: 10.1007/BF00833394. Eur J Nucl Med. 1996. PMID: 8698064

8

"High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.

Menzel C, Grünwald F, Schomburg A, Palmedo H, Bender H, Späth G, Biersack HJ. Menzel C, et al. Among authors: bender h. J Nucl Med. 1996 Sep;37(9):1496-503. J Nucl Med. 1996. PMID: 8790201 Free article.

9

18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease.

Grünwald F, Pohl C, Bender H, Hartmann A, Menzel C, Ruhlmann J, Keller E, Biersack HJ. Grünwald F, et al. Among authors: bender h. Ann Nucl Med. 1996 Feb;10(1):131-4. doi: 10.1007/BF03165066. Ann Nucl Med. 1996. PMID: 8814717

10

Possible role of FDG-PET in the evaluation of urologic malignancies.

Bender H, Schomburg A, Albers P, Ruhlmann J, Biersack HJ. Bender H, et al. Anticancer Res. 1997 May-Jun;17(3B):1655-60. Anticancer Res. 1997. PMID: 9179213 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

649 results

Search Page

Filters